ÂÜÀòÂÒÂ×

Alfredo Covelli was trained as a medical oncologist at the Department of Neoplastic Disease, Mount Sinai Hospital, New York. Before joining the pharma industry, he held academic positions at the Institute of Medical Pathology, School of Medicine in Naples and at the Division of Hematology, School of Medicine in Rome. Over the last 30 years, Dr. Covelli held a variety of Global and Country Management positions in the pharma industry, both in Clinical Research and in Commercial Operations in Italy, France, Switzerland and the United States (Farmitalia, Pierre Fabre, Sandoz, and Aventis). Before joining Philogen as Chief Medical officer, he served as Vice President and Head of Clinical Research and Medical Affairs for Europe at Novartis Oncology.

Dr. Covelli is also serving as a member of the Scientific Advisory Board to various Biotech Companies developing innovative therapies in oncology.